TREATMENT WITH THE CHIMERIC ANTIIL2R ANTIBODY BASILIXIMAB SIMULECT® AFFECTS BOTH THE IL2 AND THE IL15 SIGNALING PATHWAY AFTER CLINICAL KIDNEY TRANSPLANTATION.

Details

Language :

English

ISSN :

00411337 and 15346080

Volume :

69

Issue :

Supplement 8

Database :

Supplemental Index

Journal :

Transplantation

Publication Type :

Periodical

Accession number :

ejs50129967